Glyburide And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 65862-082

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glyburide And Metformin Hydrochloride (NDC 65862-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1.25 mg/250 mg (100 Tablets Bottle))

This is a prescription medication containing 55mg/250mg of glyburide USP and metformin hydrochloride USP. The recommended dosage information can be found on the package insert. It is advised to store the medication at 20°C to 25°C (68°F to 77°F) with permitted temperature excursions ranging from 15°C to 30°C (59°F to 86°F). The container consists of 100 tablets with child-resistant closures and is light-resistant. The medication distributed by Aurobindo Pharma USA, Inc. and manufactured in India. The code is TS/DRUGS9/1993. Not available.*

FDA Label Image

Package Label-principal Display Panel (2.5 mg/500 mg (100 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (5 mg/500 mg (100 Tablets Bottle))

FDA Label Image

Glyburide Chemical Structure (Glymet Str1)

FDA Label Image

Metformin Hydrochloride Chemical Structure (Glymet Str2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.